North America Gene Therapy Platform Market Size & Outlook
North America gene therapy platform market highlights
- The North America gene therapy platform market generated a revenue of USD 768.3 million in 2024.
- The market is expected to grow at a CAGR of 12.7% from 2025 to 2030.
- In terms of segment, viral vector platforms was the largest revenue generating type in 2024.
- Viral Vector Platforms is the most lucrative type segment registering the fastest growth during the forecast period.
North America data book summary
| Market revenue in 2024 | USD 768.3 million |
| Market revenue in 2030 | USD 1,551.5 million |
| Growth rate | 12.7% (CAGR from 2025 to 2030) |
| Largest segment | Viral vector platforms |
| Fastest growing segment | Viral Vector Platforms |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Viral Vector Platforms |
Other key industry trends
- In terms of revenue, North America region accounted for 36.0% of the global gene therapy platform market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,508.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Gene Therapy Platform Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Andelyn Biosciences | View profile | 101-250 | Columbus, Ohio, United States, North America | https://www.andelynbio.com/ |
| ElevateBio | View profile | 251-500 | Waltham, Massachusetts, United States, North America | https://www.elevate.bio |
| IDBS Group | View profile | 251-500 | Guildford, Surrey, United Kingdom, Europe | https://www.idbs.com/en/ |
| L7 Informatics | View profile | 101-250 | Austin, Texas, United States, North America | https://l7informatics.com/ |
| Hypertrust Patient Data Care | View profile | 11-50 | München, Bayern, Germany, Europe | https://www.hypertrust-patient.com/ |
| Autolomous | View profile | 11-50 | London, England, United Kingdom, Europe | https://autolomous.com/ |
| Lonza | View profile | - | - | - |
| Novartis AG | View profile | - | - | - |
| IBM | View profile | - | - | - |
| Deep Genomics | View profile | 101-250 | Toronto, Ontario, Canada, North America | http://www.deepgenomics.com/ |
| Renovaro Inc | View profile | 12 | 2080 Century Park East, Suite 906, Los Angeles, CA, United States, 90067 | https://www.enochianbio.com |
| Precision BioSciences Inc | View profile | 109 | 302 East Pettigrew Street, Dibrell Building, Suite A-100, Durham, NC, United States, 27701 | https://www.precisionbiosciences.com |
| Sarepta Therapeutics Inc | View profile | 1314 | 215 First Street, Suite 415, Cambridge, MA, United States, 02142 | https://www.sarepta.com |
| BioIT Solutions | View profile | 11-50 | Silver Spring, Maryland, United States, North America | http://www.bioit.com |
| TrakCel | View profile | 11-50 | Cardiff, Cardiff, United Kingdom, Europe | http://trakcel.com |
| CRISPR Therapeutics AG | View profile | 407 | Baarerstrasse 14, Zug, Switzerland, CH-6300 | https://www.crisprtx.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| SAP SE | View profile | 107602 | Dietmar-Hopp-Allee 16, Walldorf, BW, Germany, 69190 | https://www.sap.com |
North America gene therapy platform market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene therapy platform market will help companies and investors design strategic landscapes.
Viral vector platforms was the largest segment with a revenue share of 111.12% in 2024. Horizon Databook has segmented the North America gene therapy platform market based on viral vector platforms covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to North America gene therapy platform market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America gene therapy platform market databook
-
Our clientele includes a mix of gene therapy platform market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America gene therapy platform market , including forecasts for subscribers. This continent databook contains high-level insights into North America gene therapy platform market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
